Cargando…
Cell delivery systems: Toward the next generation of cell therapies for type 1 diabetes
Immunoprotection and oxygen supply are vital in implementing a cell therapy for type 1 diabetes (T1D). Without these features, the transplanted islet cell clusters will be rejected by the host immune system, and necrosis will occur due to hypoxia. The use of anti‐rejection drugs can help protect the...
Autores principales: | Dang, Hoang Phuc, Chen, Hui, Dargaville, Tim R., Tuch, Bernard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465194/ https://www.ncbi.nlm.nih.gov/pubmed/35975353 http://dx.doi.org/10.1111/jcmm.17499 |
Ejemplares similares
-
Nanoparticle based insulin delivery system: the next generation efficient therapy for Type 1 diabetes
por: Sharma, Garima, et al.
Publicado: (2015) -
Toward next-generation fuel cell materials
por: Shah, M.A.K. Yousaf, et al.
Publicado: (2023) -
Towards the next generation of antimalaria combination therapies
por: Möhrle, Jörg J
Publicado: (2021) -
Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells
por: Arnaud, Marion, et al.
Publicado: (2023) -
Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015)